Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase.

Ruess, Dietrich A; Heynen, Guus J; Ciecielski, Katrin J; Ai, Jiaoyu; Berninger, Alexandra; Kabacaoglu, Derya; Görgülü, Kivanc; Dantes, Zahra; Wörmann, Sonja M; Diakopoulos, Kalliope N; Karpathaki, Angeliki F; Kowalska, Marlena; Kaya-Aksoy, Ezgi; Song, Liang; van der Laan, Eveline A Zeeuw; López-Alberca, María P; Nazaré, Marc; Reichert, Maximilian; Saur, Dieter; Erkan, Mert M; Hopt, Ulrich T; Sainz, Bruno; Birchmeier, Walter; Schmid, Roland M; Lesina, Marina; Algül, Hana.
Nat Med; 24(7): 954-960, 2018 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-29808009